Photos: Øystein Horgmo, UiO and NIPH
Oslo Diabetes Research Centre unites diabetes research within Oslo University Hospital, the University of Oslo and the Norwegian Institute of Public Health.
Success in achieving International Society for Pediatric and Adolescent Diabetes’ glycemic targets varies considerably among countries. This paper seeks to evaluate how HbA1c levels and the use of diabetes technology changed in Norway from 2013 to 2022 and how different measures influence glycemic control.
Cand.med. Maryam Saeed at Institute of Clinical Medicine will be defending the thesis “Risk of Coronary Heart Disease and End-Stage Renal Disease in Type 1 Diabetes with onset before 15 years of age, 1973 - 2017” for the degree of PhD (Philosophiae Doctor).
The use of tissue continuous glucose monitoring (CGM) has increased exponentially the last five years. In the Norwegian diabetes registries 96% of children and 87% of adults with type 1 diabetes in Norway use this technology. The New England Journal ogf Medicine recently had a review article on diabetes technology.
Researchers from Oslo Diabetes Research Center today present the results of the DiVID study at the annual meeting of the European Association for the Study of Diabetes in Hamburg. The study was simultaneously published in the high-ranked medical journal Nature Medicine.
M.Sc. Nicolas Fragoso Bargas at Institute of Clinical Medicine will be defending the thesis “DNA Methylation and cardiometabolic health: associations with insuline resistance, folate, and physical activity in pregnancy” for the degree of PhD (Philosophiae Doctor).
Researchers from our center will present news about diabetes and diabetes research to the public at a meeting in Litteraturhuset, Oslo on Tuesday September 26, at 6 p.m.
Sindre Lee-Ødegård has been awarded NOK 16 million in the Excellence Emerging Investigator Grant in endocrinology and metabolism from the Novo Nordisk Foundation.